What happened: The UK has established a minimum age of 11 for children to participate in a clinical trial of puberty-blocking drugs for gender-questioning youth.
Why it matters:
- Ensures age-appropriate participation in medical research on puberty blockers.
- Affects gender-questioning children considering medical options during puberty.
MNN Take: Setting a minimum age helps regulate clinical trials and aims to protect young participants by ensuring they are mature enough to take part in such studies.
Sources: BBC Health (Lifestyle)